Navigation Links
Affymetrix and Stratagene Announce Strategic Software Alliance

are makes the industry-leading methods for measuring gene expression on a genomic-scale available to an ever broadening community of life scientists."

As part of the agreement, Stratagene has joined the community of Affymetrix partners developing methods for next-generation gene expression microarrays. "Affymetrix' tiling arrays are revolutionizing functional analysis," said Dr. Joseph A. Sorge, Chairman and CEO of Stratagene. "We believe that our technology will provide key functionality needed to support important genomic studies. In addition, we're very excited to join Affymetrix' consortium of developers in an effort to bring to market breakthrough gene expression microarray technology. By partnering with other thought leaders in our field, we believe we have the opportunity to position our technology as a standard for expression analysis."


'"/>

Source:Affymetrix


Page: 1 2

Related biology news :

1. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
2. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
3. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
4. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
5. Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX
6. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
7. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
8. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
9. Affymetrix 500K array used to identify memory gene
10. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
11. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
Post Your Comments:
(Date:12/4/2008)...cterium overcomes a tomato plant,s defences and ca...ntruder detection systems, is,revealed in new res... , The new study focuses on a pathogen which c...his bacterial invasion causes black lesions on lea...ve and costly damage to,tomato crops, and researc...
(Date:12/4/2008)...ged men want younger women, often touting their in...n research at Gothenburg University and Oxford Uni...how men and women choose partners. , Research in...pted theories about how men and women choose their...t men place more emphasis on attractive appearance...
(Date:12/3/2008)...Looking at the site today, it,s easy to forget tha...ity of Wisconsin-Madison,s Franbrook Farm Research...the structure are gone, and acres of plants, both ...er basin. , Nevertheless, memories of the dam re...UW-Madison researchers are now unearthing them. Wr...
(Date:12/3/2008)..., Mo. "FORE"...Though they may not help improve a...ge the way golfers think about the local country c... of Missouri study. , "There are more than 17,00...tely 70 percent of that land is not used for playi...ology in the MU College of Arts and Science. "Thes...
Breaking Biology News(10 mins):Red alert! How disease disables tomato plant's 'intruder alarm' 2Myth about 'dirty old men' supported by science 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Golf course: Playing fields, wildlife sanctuaries or both 2Susan G Komen for the Cures 28R 29 Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 18788 1Susan G Komen for the Cures 28R 29 Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 18788 2Susan G Komen for the Cures 28R 29 Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 18788 3Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 1Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 2Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 3Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 4Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 5Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 6Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 7Scientists identify key roadblock to gene expression 18781 1Scientists identify key roadblock to gene expression 18781 2FasterCures President Greg Simon Testifies to U S Senate HELP Committee on Cancer Challenges and Opportunities in the 21st Century 18776 1FasterCures President Greg Simon Testifies to U S Senate HELP Committee on Cancer Challenges and Opportunities in the 21st Century 18776 2
...grades faulty proteins created by the cystic fibro...h Carolina at Chapel Hill scientists. Turning off ...ain their proper shape, offering a new avenue for ...c fibrosis (CF) is a fatal disease caused by a def...protein cystic fibrosis transmembrane conductance ...
... of the breast cancer susceptibility gene BRCA1 re...mation of large blood vessels needed to support ca...n addition to an impaired DNA damage response asso...s also linked to manipulation of the tumor microen...of Cancer Cell, published by Cell Press. , Mutati...
...horse, an experimental RNA-based drug -- the first...r cells and then springs into action to destroy th...g, developed at Duke University Medical Center, us...RNA, to enter cancer cells, and another type, call...ein that keeps the cells alive. , In tests in mi...
...ated with proteins that induce bone formation may ... gum disease, researchers say. , In laboratory te...ts that directs endogenous stem cells to become bo... regeneration of lost tissue, says Dr. Ulf Wikesjö...entistry. , Loss of teeth and bone is a common a...
Other Biology News:Study reveals how cells destroy faulty proteins in cystic fibrosis 2Study identifies new role for breast cancer susceptibility gene 2Experimental RNA-based drug kills prostate cancer cells effectively and safely 2Protein-coated dental implants could improve bone regeneration 2
(Date:12/4/2008)...Dec. 4 Raymond J. De Hon... Corporation (NYSE: MPR ), announced today that t...on December 3, 2008, declared a quarterly dividend...hareholders of record at the close of business on ...% increase over the same period last year. , ,...
(Date:12/4/2008)..., Dec. 4 A 60-year-old,...e the first person in France,to be treated using ...s,(NYSE: VAR ) for fast and precise forms of in...s treatments at the CRLC Val D,Aurelle - Paul Lama...mes faster than conventional IMRT,treatments. Dr....
(Date:12/4/2008)...urth Quarter 2008 and Full Year 2009 Earnings Guid...Newswire-FirstCall/ -- DuPont, (NYSE: DD ) toda...ket challenges and strengthen the company,s compet...ximizing cash flow, and provided earnings guidance...9. , , A steep global decline in constructi...
(Date:12/4/2008)... Calif., Dec. 4 Peregr...announced that it will release its financial resul...ecember 10, 2008 at 7:00 a.m. EST and will host a ... at 11:30 a.m. EST on the same day. , , Pe... results for the second quarter ended October 31, ...
Breaking Biology Technology:Met-Pro Corporation Declares Quarterly Dividend 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 2DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 4DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 5DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 6Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2
... In debates and teaching, it is sometimes useful t...he real world resorts to such tactics, but in the ...ricanes Katrina and Rita. Since nobody in their ri...ature, I,m hoping this is a teaching moment. The q... be bright enough to learn the right lessons. , ,...
... Few things can make a professor lose his cool mor... of a lecture. The possibilities for making a mist...ofessor won,t play in the computer, audio recordin...ead projector falling to the floor. , ,On the Univ...lving such technical issues and more falls on the ...
... . -- This year the University of Wisconsin-River ...robiology Symposium, which focuses on food safety ...e Food Microbiology Symposium is Oct. 15-19 and fe...tory agencies will provide an overview on various ...rolling E. coli and other pathogens, biosecurity a...
...tended DEMOfall, held in Newport Beach, Calif., la...he most innovative new technology companies. Two d...and network with the crowd. When the conference is...business cards and a to-do list of follow-up items...r until February when we do it all over again. , ,...
Other Biology Technology:Planning, reality, good intentions and the road to ... 2Planning, reality, good intentions and the road to ... 3Planning, reality, good intentions and the road to ... 4Interest drives investment of instructional technology 2Interest drives investment of instructional technology 3Interest drives investment of instructional technology 4Now the real work begins 2Now the real work begins 3
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss
Anti-FLIPgamma / delta (CT) Antibody, Unconjugated from QED Bioscience Inc.
Phospho- (Ser) 14-3-3 Binding Motif (4E2) Mouse mAb
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798
Biology Products: